‘Will it really work?’: Young sickle cell patient among the first to start new gene therapy

‘Will it really work?’: Young sickle cell patient among the first to start new gene therapy

Since two gene therapies were approved for sickle cell disease in late 2023, only a handful of patients have started the expensive treatments.  NBC News Health

​Since two gene therapies were approved for sickle cell disease in late 2023, only a handful of patients have started the expensive treatments. 

Leave a Reply

Your email address will not be published. Required fields are marked *